Top 10 Medical Stocks To Own For 2018

Marijuana is well on its way to becoming the “norm” in modern America.

Eight states – Alaska, California, Colorado, Maine, Maryland, Massachusetts, Oregon, and Washington – and the District of Columbia have fully legalized possession of small amounts of marijuana for adults’ recreational use. An additional 13 states have decriminalized it. And 29 states, along with Puerto Rico and Guam, now allow the use of medical marijuana.

However, the drug is still classified as an illegal Schedule I substance in the eyes of the federal government.

Top 10 Medical Stocks To Own For 2018: Summer Infant Inc.(SUMR)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Childrens Placeoutperforming last year before leveling off into a range while mid cap peerCarter’s, Inc (NYSE: CRI) is nearing previous highs againand small cap Summer Infant, Inc (NASDAQ: SUMR) is well below previous highs:

Top 10 Medical Stocks To Own For 2018: Brady Corporation(BRC)

Advisors’ Opinion:

  • [By Shauna O’Brien]

    Robert Baird announced on Friday that it has cut its rating on Brady Corp (BRC).

    The firm has downgraded BRC from “Outperform” to “Neutral,” and has given the company a $33 price target. This price target suggests a 8% upside from the stock’s current price of $30.52.

    Analysts see the company’s WPS segment growing faster than expected.

    Brady shares were mostly flat during pre-market trading Friday. The stock is down 9% YTD.

  • [By Michael Flannelly]

    Before the opening bell on Thursday, identification solutions provider Brady Corp (BRC) posted a loss in the fourth quarter, despite a rise in revenues, as it was negatively impacted by a number of charges. However, excluding these charges, the company was able to top Wall Street analysts’ earnings and sales estimates. Nonetheless, BRC shares are plummeting in Thursday’s trading.

    The Milwaukee, Wisconsin-based company posted a loss from continuing operations of $176.2 million, or $3.41 per share, in the fourth quarter, versus last year’s fourth quarter earnings from continuing operations of $20.9 million, or 40 cents per share. Furthermore, Brady posted a net loss of $177.2 million, or $3.43 per share, compared to net earnings of $11.6 million, or 22 cents per share, in the same period a year ago.

    The fourth quarter loss includes non-cash impairment charges of $204.4 million, $15.6 million in restructuring charges, and $4 million in acquisition-related charges. Excluding these charges, Brady Corp said earnings would have been 53 cents per share in the quarter. According to analysts polled by Thomson Reuters, the company was expected to earn an adjusted 51 cents per share in the fourth quarter.

    The company’s fourth quarter sales came in at $309.1 million, up 15% from $269.1 million in sales posted last year. On average, analysts were expecting the company to see $307.13 million in revenues for the quarter.

    Looking ahead, Brady Corp. sees fiscal 2014 earnings coming in between $1.80 and $2.00 per share, below the analysts’ view of $2.30 per share.

    Brady Corp shares were down $1.71, or 5.25%, during early morning trading on Thursday. The stock is up 7.93% year-to-date.

  • [By Mike Deane]

    For the 28th year in a row, Brady Corp (BRC) has increased its dividend payout to investors.

    The Milwaukee, WI-based company increased its quarterly dividend to 19.5 cents from 19 cents, an increase of 2.6%. The annual dividend now stands at 78 cents. The quarterly dividend will be paid on October 31st, 2013 to all shareholders of record on October 10, 2013.

    BRC shares were down 40 cents, or 1.23%, by market close on Wednesday. YTD, the company’s stock is down over 4%.

Top 10 Medical Stocks To Own For 2018: New York & Company Inc.(NWY)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    After looking at this week’s penny stock gainers, we’ll give you that leg up with one of our top-rated penny stocks from our proprietary stock ranking system…

    Penny Stock Current Share Price (March 26) Last Week’s Gain
    Cartesian Inc. (OTCMKTS: CRTN) $0.39 170.69%
    Odyssey Marine Exploration Inc. (Nasdaq: OMEX) $8.76 135.90%
    iFresh Inc. (Nasdaq: IFMK) $8.25 64.64%
    China Auto Logistics Inc. (Nasdaq: CALI) $4.68 47.43%
    National American University Holdings Inc. (Nasdaq: NAUH) $1.20 39.29%
    Document Security Systems Inc. (NYSE: DSS) $1.58 33.91%
    Blonder Tongue Labs Inc. (NYSE: BDR) $0.77 33.90%
    CareDx Inc. (Nasdaq: CDNA) $7.49 29.88%
    Mediwound Ltd. (Nasdaq: MDWD) $5.10 26.51%
    New York & Co. Inc. (NYSE: NWY) $3.37 26.35%

    Don’t Miss This Shot at a $78,000 Windfall: This tiny firm is about to make the entire world wire-free. As its game-changing technology revolutionizes the global power structure, its stock could hand investors a massive return. Learn more…

  • [By Lisa Levin]

    Shares of New York & Company, Inc. (NYSE: NWY) got a boost, shooting up 13 percent to $2.31 as the company posted upbeat quarterly results.

    The GEO Group Inc (NYSE: GEO) shares were also up, gaining 19 percent to $23.27. Following Thursday’s Department of Justice news regarding privately-managed prisons, GEO Group dropped on Thursday, but rebounded Friday after issuing a response to the DoJ.

  • [By Monica Gerson]

    New York & Company, Inc. (NYSE: NWY) shares dropped 42 percent to $1.72 after the company reported downbeat Q1 results and issued a weak Q2 forecast.

Top 10 Medical Stocks To Own For 2018: ZTE Corporation (ZTCOF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The United States has a history of preventing Chinese companies that are even suspected of being state-owned from selling certain products into key industries. Huawei and ZTE (OTCPK:ZTCOF), for example, were under harsh scrutiny for their telecommunications equipment.

  • [By SEEKINGALPHA.COM]

    Chinese telco equipment giant ZTE (OTCPK:ZTCOF) has been actively cooperating and communicating with relevant U.S. government departments in order to reach a conclusion of the investigation related to the compny’s violations of sanctions on Iran.

Top 10 Medical Stocks To Own For 2018: NXP Semiconductors N.V.(NXPI)

Advisors’ Opinion:

  • [By Paul Ausick]

    The offer has two caveats. First, Qualcomm’s bid for NXP Semiconductor N.V. (NASDAQ: NXPI) must either be completed at that price or rejected. Second, Qualcomm may not delay or cancel its scheduled annual meeting set for March 6.

  • [By Jack Foley]

    Furthermore, the NXP Semiconductor (NSDQ:NXPI) acquisition should enable Qualcomm to really become a frontrunner in the lucrative automotive area. There have been rumors that the deal could hit some roadblocks but I see the acquisition eventually going through sometime this year. Qualcomm will want to push its processor business into the automotive market and NXP with its extensive number of loyal distributorsand customers should be able to help here in a big way. Billions are being plowed into theautonomous vehicle market at present and first mover advantage is going to be critical. One would feel that the combined technologies of the Qualcomm/NXP partnership should gain ground here as theIoT phenomenon continues to gain traction. Qualcomm already has a presence here with its Snapdragon processors in some Android Auto IVI systems. For a start, if NXP’sRFCMOS chips (which do away with multi-chip systems) can meaningfully add value to Qualcomm’s current offering in this space, the new partnership could leapfrog a number of competitors in a short span of time, which will be one more positive for QCOM stock.

  • [By Andrew Tonner]

    One of the best ways to invest in broad-based movements such as the IoT is by buying shares in the companies that supply the hardware and infrastructure powering the trend — such asSkyworks Solutions (NASDAQ:SWKS) and NXP Semiconductor (NASDAQ:NXPI). Let’s dig into each company to see what makes them two of the top IoT investments on the market today.

  • [By Sreekanth Anasa]

    Qualcomm (NASDAQ:QCOM) stock price has now fallen below the crucial 20-day, 50-day and 100-day moving averages. Its legal issues have again weighed heavy on QCOM stock of late. QCOM stock has a crucial support at the $52.66 level, which is just below the last closing price (on April 13). Qualcomm stock has not fallen below these levels in 2017.A fall below this level means QCOM stock could drop, moving close to itsone-year lows. However, two popular momentum indicators Bollinger Bands and Relative Strength Index (RSI) indicators suggest that QCOM stock is oversold. The technicals depict mixed scenario for QCOM stock. QCOM stock has lost momentum going into its Q2 earnings, with the stock losing more than 5% in the last 5 trading sessions and is still down more than 10.5% YTD. QCOM stock still makes a good long-term investment, especially with the $47B NXP Semiconductor (NASDAQ:NXPI) acquisition lined up. The smartphone chipset maker’s stock is also named the top dividend stock with insider buying and has adividend yield of 4.27%. Long-term investors with a high-risk appetite might relish buying QCOM stock at such low levels. However, it would be prudent for risk-averse investors to stay on the sidelines till the Q2 earnings, which would give a better picture of Qualcomm’s present legal woes and its future implications.

  • [By Sreekanth Anasa]

    This has the potential to offset the sluggishness in demand of smartphone chips around the world. Also, certain performance benchmarks of Qualcomm’s latest flagship processor 835 are making positive waves. A lot is riding on Qualcomm’s $47B acquisition of NXP Semiconductor (NASDAQ:NXPI), which it plans to complete by the end of the year. This acquisition would open up the high potential IoT segment as well for the smartphone chipmaker. All of these positives have been overshadowed by Qualcomm Inc’s legal troubles, which could hit its licensing business hard. Qualcomm depends heavily on its licensing business to generate bulk of its pre-tax profits. In the most recent fiscal year, Qualcomm’s QTL segment accounted for 78% of its pre-tax profits. The verdicts in the legal issues faced by Qualcomm will not be out anytime soon. These tend to be long drawn courtroom battles, and have cast a spell of uncertainty over Qualcomm’s licensing business.

  • [By Anders Bylund]

    NXP Semiconductors (NASDAQ:NXPI) is knee-deep in a pending merger with sector rival Qualcomm (NASDAQ:QCOM). There was a time when it would have made sense to pick up NXP shares, even if you missed the 25% buyout surge in September.

Top 10 Medical Stocks To Own For 2018: Long Island Iced Tea Corp. (LTEA)

Advisors’ Opinion:

  • [By ]

    Long Island Ice Tea changed its name to Long Blockchain (Nasdaq: LTEA), sending shares 200% higher. It remains to be seen how a beverage maker will create shareholder value from blockchain technology — not that its investors care.

  • [By ]

    5. Blockchain-Related Stocks
    Shorting blockchain-related stocks is an ideal way to not only short bitcoin but also short the entire cryptocurrency craze. Many such stocks exist, such as Riot Blockchain (Nasdaq: RIOT), Long Blockchain (Nasdaq: LTEA), and Longfin (Nasdaq: LFIN). Choose the one that you think is most overhyped and short away!

  • [By Garrett Baldwin]

    William may be right about a sell-off in stocks… in the cryptocurrency space. Over the last week, companies that have billed themselves as blockchain-focused saw their stocks surge. One firm – Long Island Iced Tea changed its name to Long Island Blockchain and watched its stock surge more than triple digits. But today, firms with this exposure are cratering. MGT Capital Investments Inc. (OTCMKTS: MGTI), Long Island Iced Tea Corp. (Nasdaq: LTEA), Riot Blockchain Inc. (Nasdaq: RIOT), and Siebert Financial Corp. (Nasdaq: SIEB) all fell by more than 12% Friday.

Top 10 Medical Stocks To Own For 2018: Forward Pharma A/S(FWP)

Advisors’ Opinion:

  • [By George Budwell]

    Shares of theDanish drugmaker Forward Pharma A/S (NASDAQ:FWP) gained 48.2% yesterday as the result of a settlement and licensing deal with Biogen (NASDAQ:BIIB)involving an ongoing patent dispute over the multiple sclerosis drug Tecfidera. Per the terms of the deal, Biogen will fork overa non-refundable$1.25 billion licensing fee, and possibly pay 10% to 20% royalties on Tecfidera’snet sales to Forward starting in 2021.

  • [By Jim Robertson]

    Last Friday, our Under the Radar Moversnewsletter suggested going long on small cap clinical-stage biopharmaceutical stock Forward Pharma A/S (NASDAQ: FWP):

Top 10 Medical Stocks To Own For 2018: Cardtronics, Inc.(CATM)

Advisors’ Opinion:

  • [By Timothy Green]

    Non-bank ATM operator Cardtronics (NASDAQ:CATM) slumped on Friday despite reporting fourth-quarter results that beat analyst estimates on all fronts. The culprit driving the decline may be the company’s 2017 guidance, which calls for a decline in adjusted EPS. At 2:30 p.m. EST, the stock was down about 10%.

Top 10 Medical Stocks To Own For 2018: GlobalSCAPE, Inc.(GSB)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday, our Under the Radar Moversnewsletter suggested going long on small cap sofware stockGlobalSCAPE, Inc (NYSEMKT: GSB):

    As for Globalscape, this one’s a little more straightforward, and obvious. GSB shares pushed up and off of their 200-day moving average line last week, and are making higher highs this week. What you can’t see on the chart is how this has been a pretty reliable pattern for Globalscape for years now. The upper edge of the rising trading range is nearing $6.00, though it would take some time to get there.

Top 10 Medical Stocks To Own For 2018: Insperity, Inc.(NSP)

Advisors’ Opinion:

  • [By Lee Jackson]

    Insperity Inc. (NYSE: NSP) also had a large-scale seller on the desk, and it was another well-known hedge fund. Value Act, which also serves as a director at the company, sold a total of 226,000 shares of the stock at prices that ranged from $71.22 to $72.41. The total for the sale was set at $16 million.Insperity provides an array of human resources and business solutions to enhance business performance for small and medium-sized businesses in the United States. The shares closed the day on Friday at $71.85.

Leave a Reply

Your email address will not be published. Required fields are marked *